Contemplating a future where machines break free of human meddling, with internet law expert Jonathan Zittrain.

Recursion Pharmaceuticals Inc. stocks have been trading down by -4.43 percent after AI drug-discovery partnership concerns ...

The Eureka machine will be the culmination of several converging streams of AI development. Below, Richard Socher shares five ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and ...

Since I called it three times in the recursion, the return process also happens three times. Even though I understood it in ...

The DNA inside our cells isn’t just a series of instructions, but something far more dynamic. Like scientists, AI models ...

Amodei’s most recent manifesto, “ We Must Pace the Frontier, ” calls precisely for tapping the brakes on A.I., “not just ...

Nicolai and I have been writing about entrepreneurial judgment for more than twenty years.

Tempus AI Inc. stocks have been trading up by 6.55 percent after bullish coverage on its AI-driven healthcare data platform.

It's one of AI policy's hardest unsolved problems. Expert Deb Raji joins Stanford HAI to find answers that move beyond ...

Recently, it was reported that the US AI development company Anthropic had purchased a large quantity of new books from ...

Plus, more literary recommendations from the author of Victorious.